Lupron

AbbVie in line for hefty payout after Takeda breached supply contract on Lupron
Fierce Pharma
Thu, 09/7/23 - 10:25 am
AbbVie
Takeda
legal
Lupron
No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide
Fierce Pharma
Thu, 09/9/21 - 11:09 am
AbbVie
Takeda
Lupron
drug shortages
legal
Myovant shows disappointing prostate cancer data on the way to the FDA, stock sinks
Endpoints
Tue, 09/29/20 - 12:13 pm
Myovant
Relugolix
prostate cancer
AbbVie
Lupron
clinical trials
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
AbbVie Is Expected to Strengthen Its Position in Virology in 4Q15
Yahoo/Market Realist
Tue, 01/19/16 - 09:28 am
AbbVie
hepatitis C
Lupron
Duodopa
Creon
Viekira Pak
Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Study Says
Bloomberg Businessweek
Wed, 12/7/11 - 11:05 am
prostate cancer
AstraZeneca
Watson
Lupron
Abbott Laboratories
Vantas
Trelstar
Zoladex
Endo
Abbott Labs says FDA approves longer-acting Lupron
Yahoo/AP
Wed, 08/17/11 - 08:25 am
FDA
Lupron
Abbott Laboratories
central precocious puberty
FDA Meeting Should Clarify Path for Neurocrine Bio's Efforts
Seeking Alpha
Sat, 02/12/11 - 12:16 pm
Neurocrine
Abbott Laboratories
endometriosis
Elagolix
Lupron
FDA Calls for New Warnings on Some Prostate Cancer Drugs
Yahoo/Health Day
Thu, 10/21/10 - 11:12 am
FDA
prostate cancer
Eligard
Lupron
Synarel
Trelstar
Vantas
Viadur
Zoladex
GnRH antagonists
US FDA accepts Abbott's six-month 45-mg formulation of Lupron sNDA for review
Pharmabiz
Sat, 03/13/10 - 11:07 am
Abbott Laboratories
Lupron
prostate cancer